Don't want ads? Subscribe or login now.

Allergan Must Face Breast Implant, Class Claims In MDL

By Bill Wichert · March 19, 2021, 10:24 PM EDT

Allergan came up short Friday in its attempt to escape claims in multidistrict litigation that the company hid the cancer risks of its textured breast implants, with a New Jersey federal...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

IN RE: ALLERGAN BIOCELL TEXTURED BREAST IMPLANT PRODUCTS LIABILITY LITIGATION

Case Number

2:19-md-02921

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

December 18, 2019

Recent Articles By Bill

September 10, 2024
Nelson Mullins Adds Baker Donelson Health Pro In Houston
December 13, 2023
NJ Litigator Rejoins Fox Rothschild After Healthcare GC Role
December 13, 2023
McDermott Brings Back Miami Litigator From County Atty Post
November 08, 2022
NJ Hospital Must Face Med Mal Suit As Other Hospital Exits
November 01, 2022
Rutgers Headed To Mediation Over COVID Whistleblower Suit
October 19, 2022
NJ Hospital CEO Fired Staffer For Ending Tryst, Suit Says
September 30, 2022
NJ Health System Loses Verdict To Recoup $15M Deal Fee
September 22, 2022
Rutgers Defeats Challenge To COVID-19 Vaccine Mandate
September 20, 2022
Cigna Slams NJ Lab's 'Contempt' In COVID-19 Coverage Suit
September 20, 2022
Princeton Wants To Ax Bias Suit Over COVID Policies